The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy
Abstract
Summary: Objective: To validate the A merican T hyroid A ssociation (ATA) initial risk of recurrence scheme and the M emorial S loan K ettering C ancer C enter (MSKCC) response to therapy re‐stratification approach in a large cohort of patients with differentiated thyroid cancer (DTC) treated outside of the U nited S tates. Design: Retrospective chart review. Patients: Five hundred and six patients with DTC followed for a median of 10 years after total thyroidectomy and RAI remnant ablation at a major cancer centre in B razil. Measurements: Final clinical outcomes were assessed based on A merican J oint C ancer C ommittee (AJCC)/U nion I nternationale C ontre le C ancer (UICC) staging, ATA risk stratification and response to therapy assessment (excellent, acceptable, biochemical incomplete and structural incomplete). Results: The AJCC/UICC staging system did not adequately stratify patients with regard to the risk of recurrence/persistent disease. However, the ATA system demonstrated a 13% risk of recurrent/persistent disease in low‐risk patients, 36% in intermediate risk patients, and 68% in high‐risk patients. Furthermore, an excellent response to therapy decreased the risk of recurrent/persistent disease to 1·4%. At the time of final follow‐up, 34% of the biochemical incomplete response patients had been re‐classified as having no evidence of disease (NED) without having received any additional therapy beyond continue levothyroxine suppression. Conversely, even after additional therapies, only 9% of the patients with an incomplete structural response were eventually re‐classified as NED. Conclusions: These data validate the ATA risk classification as an excellent initial predictor of recurrent/persistent disease and confirm the clinical utility of the MSKCC dynamic risk assessment system in a cohort of patients evaluated and treated outside the U nited S tates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Self-citationAmerican Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J. W. A., Wiersinga, W., & _, _. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02158 · Cited by 1,976
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
DEGROOT, L. J., KAPLAN, E. L., MCCORMICK, M., & STRAUS, F. H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-414 · Cited by 1,049
An expanded view of risk-group definition in differentiated thyroid carcinoma.
Cady, B., & Rossi, R. (1988) · PubMed · Cited by 937
Tuttle, R. M., Tala, H., Shah, J., Leboeuf, R., Ghossein, R., Gonen, M., Brokhin, M., Omry, G., Fagin, J. A., & Shaha, A. (2010) · Thyroid · doi:10.1089/thy.2010.0178 · Cited by 924
Self-citationHAY, I. D., Grant, C. S., Taylor, W. F., & McConahey, W. M. (1987) · PubMed · Cited by 764
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group
Byar, D. P., Green, S. B., Dor, P., Williams, E. D., Colon, J., van Gilse, H. A., Mayer, M., Sylvester, R. J., & Van Glabbeke, M. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90291-3 · Cited by 554
Sugitani, I., Kasai, N., Fujimoto, Y., & Yanagisawa, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00384-2 · Cited by 380
Pineda, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1488 · Cited by 362
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationRingel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Current practice in patients with differentiated thyroid cancer
Schlumberger, M., & Leboulleux, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00448-z · Cited by 342
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
Tuttle, R. M., & Alzahrani, A. S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00177 · Cited by 175
Self-citationKu, E. J., Yoo, W. S., Lee, E. K., Ahn, H. Y., Woo, S. H., Hong, J. H., Chung, H. K., & Park, J.-W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab539 · Cited by 57
Metadata
- Authors
- Vaisman, F., Momesso, D., Bulzico, D. A., Pessoa, C. H. C. N., Dias, F., Corbo, R., Vaisman, M., & Tuttle, R. M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2012-06-06
- Volume
- 77
- Issue
- 1
- Pages
- 132-138
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2034542445
- Cited by
- 267
- References
- 21
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. https://app.cochat.ai/papers/10.1111/j.1365-2265.2012.04342.x
- The paper
- Vaisman, F., Momesso, D., Bulzico, D. A., Pessoa, C. H. C. N., Dias, F., Corbo, R., Vaisman, M., & Tuttle, R. M. (2012). Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2012.04342.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.